Califano, D.; Gallo, D.; Rampioni Vinciguerra, G.L.; De Cecio, R.; Arenare, L.; Signoriello, S.; Russo, D.; Ferrandina, G.; Citron, F.; Losito, N.S.;
et al. Evaluation of Angiogenesis-Related Genes as Prognostic Biomarkers of Bevacizumab Treated Ovarian Cancer Patients: Results from the Phase IV MITO16A/ManGO OV-2 Translational Study. Cancers 2021, 13, 5152.
https://doi.org/10.3390/cancers13205152
AMA Style
Califano D, Gallo D, Rampioni Vinciguerra GL, De Cecio R, Arenare L, Signoriello S, Russo D, Ferrandina G, Citron F, Losito NS,
et al. Evaluation of Angiogenesis-Related Genes as Prognostic Biomarkers of Bevacizumab Treated Ovarian Cancer Patients: Results from the Phase IV MITO16A/ManGO OV-2 Translational Study. Cancers. 2021; 13(20):5152.
https://doi.org/10.3390/cancers13205152
Chicago/Turabian Style
Califano, Daniela, Daniela Gallo, Gian Luca Rampioni Vinciguerra, Rossella De Cecio, Laura Arenare, Simona Signoriello, Daniela Russo, Gabriella Ferrandina, Francesca Citron, Nunzia Simona Losito,
and et al. 2021. "Evaluation of Angiogenesis-Related Genes as Prognostic Biomarkers of Bevacizumab Treated Ovarian Cancer Patients: Results from the Phase IV MITO16A/ManGO OV-2 Translational Study" Cancers 13, no. 20: 5152.
https://doi.org/10.3390/cancers13205152
APA Style
Califano, D., Gallo, D., Rampioni Vinciguerra, G. L., De Cecio, R., Arenare, L., Signoriello, S., Russo, D., Ferrandina, G., Citron, F., Losito, N. S., Gargiulo, P., Simeon, V., Scambia, G., Cecere, S. C., Montella, M., Colombo, N., Tognon, G., Bignotti, E., Zannoni, G. F.,
... Baldassarre, G.
(2021). Evaluation of Angiogenesis-Related Genes as Prognostic Biomarkers of Bevacizumab Treated Ovarian Cancer Patients: Results from the Phase IV MITO16A/ManGO OV-2 Translational Study. Cancers, 13(20), 5152.
https://doi.org/10.3390/cancers13205152